Could a few days of radiation replace weeks for sarcoma patients?
NCT ID NCT05109494
First seen Jun 25, 2026 · Last updated Jul 08, 2026 · Updated 3 times
Summary
This study compares a shorter, more intense course of radiation (5 sessions) to the standard longer course (25 sessions) given before surgery for soft tissue sarcoma. The goal is to see if the shorter schedule is safe and effective at killing tumor cells. Thirty adults with sarcoma in their arms, legs, trunk, or head/neck will take part and be followed for up to 5 years.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- radiation therapy (hypofractionated or conventionally fractionated)
- What this could lead to
- If successful, this could show that a shorter course of radiation before surgery is just as safe and effective as the standard longer course, making treatment more convenient.
- What could go wrong
- This is a small, early-phase trial with only 30 participants, so results may not apply to everyone. The shorter radiation schedule might not kill as much tumor tissue or could cause different side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOFT TISSUE SARCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Wisconsin Hospital and Clinics
Madison, Wisconsin, 53705, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive antibody light up hidden tumors?
- A simple blood test may reveal hidden infertility risk in young cancer survivors
- Could a massive tissue bank unlock sarcoma's secrets?
- Can a targeted pill stall advanced sarcomas?
- Protein-Wrapped chemo aims to hit tumors harder, spare healthy cells
- Drug duo takes on rare head and neck tumors